Dysfunctional RVOT Conduit clinical trials at UCSF
1 research study open to eligible people
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
open to all eligible people
This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted valve in the pulmonic position with a clinical indication for intervention.
San Francisco, California and other locations
Our lead scientists for Dysfunctional RVOT Conduit research studies include Vaikom Mahadevan.